Cognitive impairment is a frequent and disabling feature of Parkinson's disease. Identifying the factors able to predict cognitive worsening since the early stage may improve disease management. The objective of this study was to define the best predictors of future cognitive worsening in a group of patients with newly diagnosed PD and to propose cutoff values potentially useful at the individual level.
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers
Arnaldi, Dario;De Carli, Fabrizio;Famà, Francesco;Brugnolo, Andrea;Girtler, Nicola;Picco, Agnese;Pardini, Matteo;ACCARDO, JENNIFER;PROIETTI, LUCA;Massa, Federico;Bauckneht, Matteo;Morbelli, Silvia;Sambuceti, Gianmario;Nobili, Flavio
2017-01-01
Abstract
Cognitive impairment is a frequent and disabling feature of Parkinson's disease. Identifying the factors able to predict cognitive worsening since the early stage may improve disease management. The objective of this study was to define the best predictors of future cognitive worsening in a group of patients with newly diagnosed PD and to propose cutoff values potentially useful at the individual level.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Movement_Disorders2017.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
624.01 kB
Formato
Adobe PDF
|
624.01 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
